Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Saama Technologies, Inc., a big data and analytics solutions company, announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors.
Bio-Optronics, the maker of the Clinical Conductor Clinical Trial Management System, announces the appointment of Sujay Jadhav to its Board of Directors.
LabConnect, LLC, a global provider of central laboratory and support services for biopharmaceutical, medical device, and CROs, announces the promotion of three executives to top-level management positions: Barry Simms, MBA, as Chief Operating Officer, Trenton Harris, MSM/MBA, as Executive Vice President and Elizabeth Koury, MS, as Vice President, scientific affairs.
Clinipace, a global full-service CRO, expands its leadership team by appointing Dawn Sauro as Chief Development Officer and Sharon Moore as Chief Medical Officer.
InClinica, a global clinical CRO, announced that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development and Anthony J. Esposito, Jr. has been appointed Senior Director of Quality Assurance.
Business News
Veeva Systems, a cloud-based solutions provider, announced that 12 adapters including a top 20 pharmaceutical company and CROs are now using Veeva Vault EDC to improve data management in their clinical trials.
Novotech, an Asia-Pacific CRO, announced that it has signed Memorandum of Understandings with five medical institutions in the region.
Clinipace, a global full-service CRO, expands its leadership team and launches a new brand identity, CHALLENGE ACCEPTED, to support its future growth as a midsized CRO.
proinnovera GmbH, a full service CRO, announced the establishment of the Company’s wholly owned subsidiary, proinnovera Inc. in North Carolina.
Recognition
Certara, a drug development consultancy, served as a key member of the MDGH drug development team when they were granted FDA approval for moxidectin for river blindness.
Navitas Life Sciences, a full service Clinical, Regulatory & Safety solutions and services provider, announced that it has been recognized as a ‘Leader’ in the IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.